| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Clinical utility of circulating tumor-associated cells to predict and monitor chemo-response in solid tumors
|
Crook, Timothy
|
|
|
87 |
2 |
p. 197-205
|
artikel
|
| 2 |
Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega-3 polyunsaturated fatty acid eicosapentaenoic acid
|
Volpato, Milene
|
|
|
87 |
2 |
p. 173-184
|
artikel
|
| 3 |
Disulfiram: a novel repurposed drug for cancer therapy
|
Lu, Chen
|
|
|
87 |
2 |
p. 159-172
|
artikel
|
| 4 |
Dynamic changes of CTCs in patients with metastatic HR(+)/HER2(−) breast cancer receiving salvage treatment with everolimus/exemestane
|
Spiliotaki, Maria
|
|
|
87 |
2 |
p. 277-287
|
artikel
|
| 5 |
Enhancing the activity of platinum-based drugs by improved inhibitors of ERCC1–XPF-mediated DNA repair
|
Ciniero, Gloria
|
|
|
87 |
2 |
p. 259-267
|
artikel
|
| 6 |
Evaluation of the impact of renal impairment on the pharmacokinetics of glasdegib in otherwise healthy volunteers
|
Shaik, Naveed
|
|
|
87 |
2 |
p. 241-250
|
artikel
|
| 7 |
Impact of interstitial lung disease associated with immune checkpoint inhibitors on prognosis in patients with non-small-cell lung cancer
|
Yamagata, Akira
|
|
|
87 |
2 |
p. 251-258
|
artikel
|
| 8 |
Monitoring of EGFR mutations in circulating tumor DNA of non-small cell lung cancer patients treated with EGFR inhibitors
|
Verheijen, R. B.
|
|
|
87 |
2 |
p. 269-276
|
artikel
|
| 9 |
Overriding sorafenib resistance via blocking lipid metabolism and Ras by sphingomyelin synthase 1 inhibition in hepatocellular carcinoma
|
Lu, Haofeng
|
|
|
87 |
2 |
p. 217-228
|
artikel
|
| 10 |
PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1
|
Yu, Shuo
|
|
|
87 |
2 |
p. 207-215
|
artikel
|
| 11 |
Pegylated liposomal doxorubicin-induced renal toxicity in retroperitoneal liposarcoma: a case report and literature review
|
Savani, Malvi
|
|
|
87 |
2 |
p. 289-294
|
artikel
|
| 12 |
Population pharmacokinetic and pharmacodynamic modeling of capecitabine and its metabolites in breast cancer patients
|
Lunar, Nastja
|
|
|
87 |
2 |
p. 229-239
|
artikel
|
| 13 |
Population pharmacokinetics of ATR inhibitor berzosertib in phase I studies for different cancer types
|
Terranova, Nadia
|
|
|
87 |
2 |
p. 185-196
|
artikel
|
| 14 |
Tumor microenvironment promotes breast cancer chemoresistance
|
Mehraj, Umar
|
|
|
87 |
2 |
p. 147-158
|
artikel
|
Tijdschrift beschrijving